Cathy Eng

41PUBLICATIONS

203CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsPredictive and prognostic markersOncology and carcinogenesis not elsewhere classified

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (41)

Sort by Publication Date:

|May 08, 2026

Trends in primary surgery and overall survival in non-metastatic anal cancer: a population-based analysis.

|Apr 21, 2026

Amivantamab Monotherapy in Chemorefractory <i>RAS</i>/<i>BRAF</i> Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

|Feb 02, 2026

Bridging the Gap: Transforming Total Neoadjuvant Therapy: NEOTERIC Signals a Step Forward in the Treatment of Locally Advanced Rectal Cancer.

Christopher G Cann, Cathy Eng, Ramya Thota

|Jan 07, 2026

NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal.

Van K Morris, Kristen K Ciombor, Lianchun Xiao

|Aug 01, 2025

A blueprint for creating an early-onset colorectal cancer program based on experiences from 7 clinical centers across the United States and Canada.

Kimmie Ng, Cathy Eng, Petra Wildgoose

|Jul 03, 2025

Cancer in the Prime of Life: Etiologic Insights and Supportive Oncologic Interventions for the Rising Burden of Young Adult Cancer.

Christopher G Cann, Cathy Eng

Pageof 7

Frequent Collaborators

Van Karlyle Morris

Al B Benson

Josep Tabernero

Kristen K Ciombor

Jennifer A Dorth

Andreana N Holowatyj

Michael LaPelusa

Eric Van Cutsem

Arvind Dasari

Takayuki Yoshino

Frequent Collaborators

Van Karlyle Morris

Al B Benson

Josep Tabernero

Kristen K Ciombor